The filing signals an officer's intent to sell a modest position. Monitor for actual sale execution on Form 4; the amount is not material relative to CME's size, so no significant price impact is expected.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $304.06entry
- T+1 · 13d ago +1.38%α −0.27% · $308.27
- T+5 · 7d ago +1.65%α +2.24% · $309.09
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Julie Winkler, an officer of CME Group, filed a Form 144 notice of intent to sell 10,079 shares of common stock with an approximate market value of $3.08 million, based on the filing date. The shares were acquired through restricted stock and performance share grants from 2020 to 2025. The sale is scheduled for November 2, 2026, and represents a routine insider sale relative to CME's $106.1B market cap.
Key Facts
- Julie Winkler, an officer of CME Group, filed Form 144 to sell 10,079 shares of common stock.
- The approximate market value of the proposed sale is $3,075,614.91.
- Shares were acquired through restricted stock and performance share grants between September 2020 and March 2025.
- The proposed sale date is November 2, 2026.
- The sale represents about 0.003% of CME's $106.1B market cap.
- Recent insider activity (30 days) shows 2 sells totaling $1.6M, making this filing a larger single insider sale.
Financial Impact
Proposed sale of 10,079 shares valued at approximately $3.08 million, representing a small fraction of CME's $106.1B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- The filing does not disclose the insider's remaining holdings, so the proportional impact of the sale is unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010593 |
| Document: 0001950047-26-010593-index.html | 0001950047-26-010593 |
| Document: 0001950047-26-010593.txt | 0001950047-26-010593 |
Track record
29 reports on CME
4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +17.81% at T+60 after the Mar 12, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $315.87 Now $319.37 +1.11% settles Feb 9
- Nov 9, 20267d ago 144 Neutral 1/10 Entry $304.52 Now $319.37 +4.88% settles Feb 5
- Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $308.27 Now $319.37 +3.60% settles Feb 2
- Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 3 Neutral 2/10 Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $304.06 Now $319.37 +5.04% settles Feb 1
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $306.24 Now $319.37 +4.29% settles Jan 29
- Oct 27, 202620d ago Insider Cluster Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $294.04 Now $319.37 +8.61% settles Jan 26
- Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $305.71 Now $319.37 +4.47% settles Jan 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers